| |
|
|
|
vTv Therapeutics Inc.  
|
|
1.44 -0.07 (-0.05%) |
11-11 15:59 |
|
Open: |
1.66 |
Pre close: |
1.51 |
Target:
|
1.82
|
|
High: |
1.66 |
Low: |
1.42 |
Resistance:
|
1.56
1.69
|
|
Volume: |
153,807 |
Market Cap: |
85M |
Support:
|
1.35
1.12
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.42
 |
MACD |
MACD(12,26):
|
-0.01 |
|
MA(20): |
1.45 |
Signal(12,26,9): |
-0.01  |
|
MA(100): |
1.42 |
Stochastic Oscillator |
%K(14,3):
|
26.69 |
|
MA(250): |
1.73 |
%D(3): |
18.54 |
|
Average Volume(K) |
3-Month: |
31327
|
52-Week |
High:
|
3.50 |
|
10-Days: |
20667 |
Low: |
1.00 |
|
RSI |
RSI(14):
|
49.12 |
Change(%): |
-40.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.584 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
34.07 |
|
EPS Est. Current Year |
-1.060 |
Return on Assets (ttm) |
-91.9 |
Shares Float (M) |
10.43 |
|
EPS Est. Next Year |
-2.250 |
PEG Ratio |
0.00 |
% Held by Insiders |
69.32 |
|
EPS Est. Next Quarter |
0.190 |
Qtrly Rev. Growth |
-99.8 |
% Held by Institutions |
2.20 |
|
Forward EPS |
-1.728 |
Gross Profit (p.s.) |
-0.311 |
Shares Short (K) |
1380 |
|
Book Value (p.s.) |
-1.330 |
EBITDA (p.s.) |
-0.432 |
P/E |
-2.47 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-1.08 |
|
Profit Margin |
-133.76 |
Operating Cash Flow
(M) |
-23.01 |
P/S |
4.96 |
|
Operating Margin |
-204.08 |
Levered Free Cash Flow
(M) |
-17.14 |
P/CF |
-2.13 |
|
|
|
|
|
|
